Ridha Joober

Ridha Joober's AcademicInfluence.com Rankings

Ridha Joober

Biology

#12696

World Rank

#16190

Historical Rank

Genetics

#1402

World Rank

#1504

Historical Rank

Molecular Biology

#2086

World Rank

#2118

Historical Rank

Neuroscience

#2149

World Rank

#2210

Historical Rank

biology Degrees

Download Badge

Biology

Ridha Joober's Degrees

PhD Neuroscience McGill University

Why Is Ridha Joober Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ridha Joober's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Increased exonic de novo mutation rate in individuals with schizophrenia (2011) (457)
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia (2010) (350)
LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia (2007) (334)
Novel de novo SHANK3 mutation in autistic patients (2009) (303)
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. (2009) (285)
Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. (1999) (275)
Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia (2011) (274)
Publication bias: what are the challenges and can they be overcome? (2012) (256)
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia (2011) (246)
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. (2010) (239)
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. (2010) (213)
Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. (2002) (204)
Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia (2011) (198)
Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. (2004) (181)
Dopamine genes and attention-deficit hyperactivity disorder: a review. (2003) (178)
Mutations in the calcium-related gene IL1RAPL1 are associated with autism. (2008) (176)
Intranasal oxytocin attenuates the cortisol response to physical stress: A dose–response study (2012) (171)
Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls (2011) (168)
De Novo SYNGAP1 Mutations in Nonsyndromic Intellectual Disability and Autism (2011) (164)
Differential effects of adrenergic and corticosteroid hormonal systems on human short- and long-term declarative memory for emotionally arousing material. (2004) (159)
NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population (2005) (135)
T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. (1999) (132)
From early intervention in psychosis to youth mental health reform: a review of the evolution and transformation of mental health services for young people (2016) (130)
Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. (2008) (127)
Evidence for a role of phospholipase C-γ1 in the pathogenesis of bipolar disorder (1998) (126)
Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings. (2005) (116)
Maternal Stress during Pregnancy, ADHD Symptomatology in Children and Genotype: Gene-Environment Interaction. (2012) (115)
Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. (2009) (112)
First-Episode Psychosis, Early Intervention, and Outcome: What Have We Learned? (2005) (109)
Early Intervention for Psychosis: A Canadian Perspective (2015) (104)
The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes. (2005) (103)
Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls? (2008) (103)
Informative phenotypes for genetic studies of psychiatric disorders (2007) (102)
Youth Mental Health Should Be a Top Priority for Health Care in Canada (2018) (100)
Cortisol response to a psychosocial stressor in schizophrenia: Blunted, delayed, or normal? (2009) (99)
Validation of the English and French versions of the Community Assessment of Psychic Experiences (CAPE) with a Montreal community sample (2007) (96)
Fundamental Movement Skills and Children with Attention-Deficit Hyperactivity Disorder: Peer Comparisons and Stimulant Effects (2007) (96)
Intranasal oxytocin and salivary cortisol concentrations during social rejection in university students (2012) (95)
Association between the methylenetetrahydrofolate reductase 677C→T missense mutation and schizophrenia (2000) (92)
Duration of untreated psychosis is associated with orbital–frontal grey matter volume reductions in first episode psychosis (2011) (91)
Toward a model of cognitive insight in first-episode psychosis: verbal memory and hippocampal structure. (2010) (91)
Methylation of BDNF in women with bulimic eating syndromes: Associations with childhood abuse and borderline personality disorder (2014) (89)
The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis. (2014) (89)
Determinants of help-seeking and system related components of delay in the treatment of first-episode psychosis (2007) (86)
Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population (2004) (84)
Childhood trauma and dissociation in first-episode psychosis, chronic schizophrenia and community controls (2013) (84)
Neural correlates of eye tracking deficits in first-degree relatives of schizophrenic patients: a positron emission tomography study. (1999) (83)
The acute effects of intranasal oxytocin on automatic and effortful attentional shifting to emotional faces. (2012) (81)
Physical activity experiences of boys with and without ADHD. (2009) (81)
Declarative memory after stress in humans: differential involvement of the beta-adrenergic and corticosteroid systems. (2005) (80)
Early Predictors of Nonadherence to Antipsychotic Therapy in First-Episode Psychosis (2009) (80)
Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study. (2011) (79)
"Mental illness is like any other medical illness": a critical examination of the statement and its impact on patient care and society. (2015) (78)
De novo variants in sporadic cases of childhood onset schizophrenia (2015) (75)
Cognitive insight and verbal memory in first episode of psychosis (2008) (74)
Identifying persistent negative symptoms in first episode psychosis (2012) (74)
Performance on the continuous performance test in children with ADHD is associated with sleep efficiency. (2007) (73)
Evaluating accuracy of striatal, pallidal, and thalamic segmentation methods: Comparing automated approaches to manual delineation (2017) (71)
The 5HTTLPR polymorphism, prior maltreatment and dramatic-erratic personality manifestations in women with bulimic syndromes. (2007) (71)
Education modulates cortisol reactivity to the Trier Social Stress Test in middle-aged adults (2007) (71)
TPH and suicidal behavior: a study in suicide completers (2001) (70)
Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo. (2004) (70)
Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies (2011) (70)
Mental wellness in Canada's Aboriginal communities: striving toward reconciliation. (2015) (69)
Dopamine Transporter 3′-UTR VNTR Genotype and ADHD: a Pharmaco-Behavioural Genetic Study with Methylphenidate (2007) (68)
What do DNA methylation studies tell us about depression? A systematic review (2019) (68)
Methylation of the dopamine D2 receptor (DRD2) gene promoter in women with a bulimia-spectrum disorder: associations with borderline personality disorder and exposure to childhood abuse. (2014) (67)
Is the Inattentive Subtype of ADHD Different From the Combined/Hyperactive Subtype? (2010) (66)
Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial. (2006) (65)
Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers (2002) (64)
Provisional Mapping of Quantitative Trait Loci Modulating the Acoustic Startle Response and Prepulse Inhibition of Acoustic Startle (2002) (64)
Selective abnormal modulation of hippocampal activity during memory formation in first-episode psychosis. (2007) (64)
Association between obesity‐related gene FTO and ADHD (2013) (63)
Canadian response to need for transformation of youth mental health services: ACCESS Open Minds (Esprits ouverts) (2018) (63)
Cortical thickness is associated with poor insight in first-episode psychosis. (2011) (61)
Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories (2008) (61)
Catechol-O-Methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD (2004) (60)
Blunted cortisol awakening response in men with first episode psychosis: Relationship to parental bonding (2013) (59)
APOE2 Is Associated with Spatial Navigational Strategies and Increased Gray Matter in the Hippocampus (2016) (58)
The brain-derived neurotrophic factor Val66Met polymorphism is associated with reduced functional magnetic resonance imaging activity in the hippocampus and increased use of caudate nucleus-dependent strategies in a human virtual navigation task (2011) (58)
Molecular cloning and characterization of human RAI1, a gene associated with schizophrenia. (2003) (58)
Development and persistence of posttraumatic stress disorder and the 5-HTTLPR polymorphism. (2009) (57)
Mutation screening of FOXP2 in individuals diagnosed with autistic disorder (2003) (57)
MAOA: association and linkage studies with lithium responsive bipolar disorder. (1999) (57)
LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy. (2012) (57)
DRD3 and DAT1 genes in schizophrenia: an association study. (2000) (57)
Comparing three‐year extension of early intervention service to regular care following two years of early intervention service in first‐episode psychosis: a randomized single blind clinical trial (2017) (54)
Maternal smoking during pregnancy and ADHD: a comprehensive clinical and neurocognitive characterization. (2013) (53)
Is the Clinical High-Risk State a Valid Concept? Retrospective Examination in a First-Episode Psychosis Sample. (2017) (53)
DNA methylation in individuals with anorexia nervosa and in matched normal-eater controls: A genome-wide study. (2015) (52)
Lithium responsive bipolar disorder, unilineality, and chromosome 18: A linkage study. (1999) (51)
Association of trait-defined, eating-disorder sub-phenotypes with (biallelic and triallelic) 5HTTLPR variations. (2009) (51)
Cognitive markers of short-term clinical outcome in first-episode psychosis (2008) (50)
Association of the promoter polymorphism −1438G/A of the 5‐HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa (2005) (49)
Clozapine: a distinct, poorly understood and under-used molecule. (2010) (49)
Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD (2011) (49)
Clinical Response to Methylphenidate in Children Diagnosed with Attention-Deficit Hyperactivity Disorder and Comorbid Psychiatric Disorders (2010) (48)
Dopamine Beta‐Hydroxylase (DBH) gene and schizophrenia phenotypic variability: A genetic association study (2003) (48)
Association between schizophrenia and genetic variation in DCC: A case–control study (2012) (48)
Coping style moderates the effect of intranasal oxytocin on the mood response to interpersonal stress. (2012) (48)
Transcriptome-wide association study of attention deficit hyperactivity disorder identifies associated genes and phenotypes (2019) (47)
A Comparison Study of Multiple Measures of Adherence to Antipsychotic Medication in First-Episode Psychosis (2010) (47)
Intranasal oxytocin impedes the ability to ignore task-irrelevant facial expressions of sadness in students with depressive symptoms (2013) (46)
Disengagement in immigrant groups receiving services for a first episode of psychosis (2017) (46)
Association and linkage studies of candidate genes involved in GABAergic neurotransmission in lithium-responsive bipolar disorder. (2000) (46)
Delusions are associated with low self-reflectiveness in first-episode psychosis (2009) (44)
Analysis of 14 CAG repeat-containing genes in schizophrenia. (1999) (44)
Schizophrenia and chromosome 6p. (1997) (44)
Sleep and COMT polymorphism in ADHD children: preliminary actigraphic data. (2006) (44)
Diagnostic Stability of First-Episode Psychotic Disorders and Persistence of Comorbid Psychiatric Disorders over 1 Year (2013) (44)
Understanding putative risk factors for schizophrenia: retrospective and prospective studies. (2005) (44)
De Novo Truncating Mutation in Kinesin 17 Associated with Schizophrenia (2010) (43)
Relevance of the 5-HTTLPR polymorphism and childhood abuse to increased psychiatric comorbidity in women with bulimia-spectrum disorders. (2008) (43)
The Structural Neural Substrates of Persistent Negative Symptoms in First-Episode of Non-Affective Psychosis: A Voxel-Based Morphometry Study (2012) (42)
Gender differences in childhood trauma in first episode psychosis: Association with symptom severity over two years (2019) (42)
Transforming youth mental health: a Canadian perspective (2015) (42)
A five-year randomized parallel and blinded clinical trial of an extended specialized early intervention vs. regular care in the early phase of psychotic disorders: study protocol (2015) (41)
Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly (2013) (41)
Reduced hippocampal volume and hypothalamus–pituitary–adrenal axis function in first episode psychosis: Evidence for sex differences (2014) (41)
Amphetamine-Induced Dopamine Release and Neurocognitive Function in Treatment-Naive Adults with ADHD (2014) (40)
Cortical Thinning in Temporo-Parietal Junction (TPJ) in Non-Affective First-Episode of Psychosis Patients with Persistent Negative Symptoms (2014) (40)
Symptom Attribution in first episode psychosis: A cortical thickness study (2012) (40)
Sex differences in the cortisol response to awakening in recent onset psychosis (2008) (40)
Reading impairments in schizophrenia relate to individual differences in phonological processing and oculomotor control: evidence from a gaze-contingent moving window paradigm. (2013) (39)
Relationship between response to methylphenidate treatment in children with ADHD and psychopathology in their families. (2006) (39)
Dopamine-system genes, childhood abuse, and clinical manifestations in women with Bulimia-Spectrum Disorders. (2012) (39)
Genetic Evidence for the Association of the Hypothalamic–Pituitary–Adrenal (HPA) Axis with ADHD and Methylphenidate Treatment Response (2013) (38)
Limbic response to psychosocial stress in schizotypy: A functional magnetic resonance imaging study (2011) (38)
COMT Val108/158Met gene variant, birth weight, and conduct disorder in children with ADHD. (2006) (38)
Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype. (2012) (37)
The Influence of Perceived Social Support on Medication Adherence in First-Episode Psychosis (2013) (36)
The effects of glucocorticoids on the inhibition of emotional information: A dose–response study (2011) (35)
Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder. (2009) (35)
Comparing the Clinical Presentation of First-Episode Psychosis across Different Migrant and Ethnic Minority Groups in Montreal, Quebec (2012) (35)
Cognitive insight in first-episode schizophrenia: Further evidence for a role of the ventrolateral prefrontal cortex (2015) (35)
Student teacher experiences in a service-learning project for children with attention-deficit hyperactivity disorder (2013) (35)
Dissocial behavior, the 5HTTLPR polymorphism, and maltreatment in women with bulimic syndromes (2008) (35)
Lack of association between the hSKCa3 channel gene CAG polymorphism and schizophrenia. (1999) (34)
[Mortality and cause of death in schizophrenia. Review of the literature]. (1993) (34)
Serotonin-system polymorphisms (5-HTTLPR and -1438G/A) and responses of patients with bulimic syndromes to multimodal treatments. (2008) (34)
A 12‐month outcome study of insight and symptom change in first‐episode psychosis (2010) (34)
Effectiveness of a Therapeutic Summer Camp for Children With ADHD (2012) (34)
Body Weight and ADHD: Examining the Role of Self-Regulation (2013) (34)
COMT Val108/158Met Polymorphism and the Modulation of Task-Oriented Behavior in Children with ADHD (2008) (34)
Association of a risk allele of ANK3 with cognitive performance and cortical thickness in patients with first-episode psychosis. (2014) (34)
Schizotypy, attention deficit hyperactivity disorder, and dopamine genes (2006) (34)
Implications of the COVID-19 pandemic for patients with schizophrenia spectrum disorders: narrative review (2021) (33)
Neural markers of remission in first-episode schizophrenia: A volumetric neuroimaging study of the hippocampus and amygdala (2010) (33)
Comprehensive Phenotype/Genotype Analyses of the Norepinephrine Transporter Gene (SLC6A2) in ADHD: Relation to Maternal Smoking during Pregnancy (2012) (33)
Contributions of the glucocorticoid receptor polymorphism (Bcl1) and childhood abuse to risk of bulimia nervosa (2011) (32)
Intrafamilial Correspondences on Platelet [3H-]Paroxetine-Binding Indices in Bulimic Probands and their Unaffected First-Degree Relatives (2006) (31)
Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis (2012) (31)
The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD (2010) (31)
Lack of association between bipolar disorder and tyrosine hydroxylase (1997) (31)
Linking persistent negative symptoms to amygdala–hippocampus structure in first-episode psychosis (2017) (31)
Psychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gap. (2015) (30)
Impairment in verbal memory observed in first episode psychosis patients with persistent negative symptoms (2013) (30)
Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis (2009) (30)
Neural markers of early remission in first-episode schizophrenia: A volumetric neuroimaging study of the parahippocampus (2012) (30)
Family history and APOE4 risk for Alzheimer's disease impact the neural correlates of episodic memory by early midlife (2017) (29)
Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients (2005) (29)
Association between 7q31 markers and tourette syndrome (2004) (29)
The parahippocampal gyrus as a neural marker of early remission in first-episode psychosis: a voxel-based morphometry study. (2011) (29)
The Clinic for Assessment of Youth at Risk (CAYR): 10 years of service delivery and research targeting the prevention of psychosis in Montreal, Canada (2017) (29)
Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis (2009) (29)
Disrupted integrity of the fornix in first-episode schizophrenia (2010) (28)
Genetics of schizophrenia: from animal models to clinical studies. (2002) (28)
Polygenic Risk Score associated with specific symptom dimensions in first-episode psychosis (2017) (28)
Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis (2019) (28)
Association and linkage studies of CRH and PENK genes in bipolar disorder: a collaborative IGSLI study. (2000) (28)
P300 asymmetry and positive symptom severity: A study in the early stage of a first episode of psychosis (2007) (27)
Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders (2005) (27)
Structure of Spike Count Correlations Reveals Functional Interactions between Neurons in Dorsolateral Prefrontal Cortex Area 8a of Behaving Primates (2013) (27)
Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD (2008) (27)
GENOME-WIDE ANALYSES OF ADHD IDENTIFY 27 RISK LOCI, REFINE THE GENETIC ARCHITECTURE AND IMPLICATE SEVERAL COGNITIVE DOMAINS (2022) (26)
Diffusion tensor imaging tractography of the fornix and belief confidence in first-episode psychosis (2012) (25)
A longitudinal, epigenome-wide study of DNA methylation in anorexia nervosa: results in actively ill, partially weight-restored, long-term remitted and non-eating-disordered women (2019) (25)
“Worried about relapse”: Family members’ experiences and perspectives of relapse in first‐episode psychosis (2019) (25)
Family-based association study of common variants, rare mutation study and epistatic interaction detection in HDAC genes in schizophrenia (2014) (25)
Adherence to psychostimulant medication in children with attention-deficit/hyperactivity disorder: the role of attitudes. (2013) (24)
Epistatic interactions implicating dopaminergic genes in bulimia nervosa (BN): Relationships to eating- and personality-related psychopathology (2012) (24)
Age-related cortical thickness trajectories in first episode psychosis patients presenting with early persistent negative symptoms (2016) (24)
Delayed sleep phase syndrome, ADHD, and bright light therapy. (2007) (24)
Effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains (2003) (23)
Polyglutamine-containing proteins in schizophrenia (1999) (23)
A NEET distinction: youths not in employment, education or training follow different pathways to illness and care in psychosis (2018) (23)
Apolipoprotein E genotype in schizophrenia. (1996) (23)
TCF4 gene polymorphism and cognitive performance in patients with first episode psychosis (2014) (23)
Interaction of the BcII glucocorticoid receptor polymorphism and childhood abuse in Bulimia Nervosa (BN): relationship to BN and to associated trait manifestations. (2012) (23)
Effects of methylphenidate on basic and higher-order oculomotor functions (2012) (23)
Autism spectrum disorders associated with X chromosome markers in French-Canadian males (2006) (23)
Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms (2016) (22)
Intranasal oxytocin attenuates the human acoustic startle response independent of emotional modulation. (2014) (22)
Is there an association between neurocognitive performance and medication adherence in first episode psychosis? (2010) (22)
Case Manager- and Patient-Rated Alliance as a Predictor of Medication Adherence in First-Episode Psychosis (2012) (22)
Acute and long-term associations between ApoE genetic polymorphism, cortisol levels, and declarative memory performance in older adults (2008) (22)
Pathways to functional outcomes following a first episode of psychosis: The roles of premorbid adjustment, verbal memory and symptom remission (2018) (22)
Cultural and Contextual Adaptation of an eHealth Intervention for Youth Receiving Services for First-Episode Psychosis: Adaptation Framework and Protocol for Horyzons-Canada Phase 1 (2018) (22)
Social cognitive markers of short-term clinical outcome in first-episode psychosis. (2010) (22)
Mesocorticolimbic Connectivity and Volumetric Alterations in DCC Mutation Carriers (2018) (22)
Impact of symptom resolution on medication adherence in first episode psychosis (2012) (22)
Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia. (2012) (22)
Concerns reported by family members of individuals with first‐episode psychosis (2011) (22)
Cognitive deficits characterization using the CogState Research Battery in first-episode psychosis patients (2015) (21)
Early intervention in psychosis: specialized intervention and early case identification. (2010) (21)
The Effect of Maternal Stress during Pregnancy on IQ and ADHD Symptomatology. (2015) (21)
No association between the DRD3 Ser9Gly polymorphism and schizophrenia (2008) (21)
Subjective distress in first‐episode psychosis: role of symptoms and self‐esteem (2007) (21)
Locus-specific DNA methylation changes and phenotypic variability in children with attention-deficit hyperactivity disorder (2017) (20)
The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study (2016) (20)
Increased Risk of Asthma in Children with ADHD: Role of Prematurity and Maternal Stress during Pregnancy. (2015) (20)
Comparison of clinical outcomes following 2 years of treatment of first-episode psychosis in urban early intervention services in Canada and India. (2020) (20)
Short duration of untreated psychosis enhances negative symptom remission in extended early intervention service for psychosis (2019) (20)
A minimum evaluation protocol and stepped-wedge cluster randomized trial of ACCESS Open Minds, a large Canadian youth mental health services transformation project (2019) (20)
What Is the Place of Clozapine in the Treatment of Early Psychosis in Canada? (2017) (19)
Medication-Adherent First-Episode Psychosis Patients Also Relapse: Why? (2012) (19)
Investigation of white matter abnormalities in first episode psychosis patients with persistent negative symptoms (2015) (19)
Polymorphism of the 5-HT2A Receptor Gene: Association with Stress-Related Indices in Healthy Middle-Aged Adults (2007) (19)
Influence of genetic polymorphisms in the apolipoprotein (APOE) and the butyrylcholinesterase (BCHE) gene on stress markers in older adults: A 3-year study (2009) (19)
Parental psychopathology in families of children with attention-deficit/hyperactivity disorder and exposed to maternal smoking during pregnancy. (2015) (19)
Behavioral response to methylphenidate challenge: influence of early life parental care. (2009) (19)
A controlled evaluation of a targeted early case detection intervention for reducing delay in treatment of first episode psychosis (2014) (19)
Children say the darndest things: physical activity and children with attention-deficit hyperactivity disorder (2014) (18)
Changes in memory performance over a 12-month period in relation to achieving symptomatic remission after a first-episode psychosis (2014) (18)
Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis (2016) (18)
Comparing cognitive clusters across first- and multiple-episode of psychosis (2018) (18)
Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study (2016) (18)
Duration of active psychosis and first‐episode psychosis negative symptoms (2017) (18)
A longitudinal study of cognitive insight and cortical thickness in first-episode psychosis (2017) (17)
Lack of association between bipolar disorder and tyrosine hydroxylase: a meta-analysis. (1996) (17)
The Trier Social Stress Test in first episode psychosis patients: Impact of perceived stress, protective factors and childhood trauma (2019) (17)
Smoking status and its relationship to demographic and clinical characteristics in first episode psychosis. (2017) (17)
Attention and Executive Function in Children Diagnosed with Attention Deficit Hyperactivity Disorder and Comorbid Disorders. (2017) (16)
Polyglutamine coding genes in bipolar disorder: lack of association with selected candidate loci. (2000) (16)
Investigation of rare variants in LRP1, KPNA1, ALS2CL and ZNF480 genes in schizophrenia patients reflects genetic heterogeneity of the disease (2013) (16)
Childhood symptoms of inattention–hyperactivity predict cannabis use in first episode psychosis (2011) (16)
A new wave in the genetics of psychiatric disorders: the copy number variant tsunami. (2009) (16)
Sex Differences in Clinical and Functional Outcomes among Patients Treated in an Early Intervention Service for Psychotic Disorders: An Observational Study (2019) (16)
Mutation Burden of Rare Variants in Schizophrenia Candidate Genes (2015) (16)
Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder (2021) (15)
Polyglutamine tracts: no evidence of a major role in bipolar disorder (1999) (15)
Relapse Risk Assessment in Early Phase Psychosis: The Search for a Reliable and Valid Tool (2014) (15)
Sex Differences in Verbal Memory Predict Functioning Through Negative Symptoms in Early Psychosis. (2020) (15)
Adaptation of a Digital Health Innovation to Prevent Relapse and Support Recovery in Youth Receiving Services for First-Episode Psychosis: Results From the Horyzons-Canada Phase 1 Study (2020) (15)
Structural Associations of Cortical Contrast and Thickness in First Episode Psychosis. (2019) (15)
Longitudinal trajectory of clinical insight and covariation with cortical thickness in first-episode psychosis. (2017) (15)
Differential Associations between Cortical Thickness and Striatal Dopamine in Treatment-Naïve Adults with ADHD vs. Healthy Controls (2017) (14)
Epistatic interactions involving DRD2, DRD4, and COMT polymorphisms and risk of substance abuse in women with binge-purge eating disturbances. (2016) (14)
Progress of negative symptoms over the initial 5 years of a first episode of psychosis (2018) (14)
Clinical and functional implications of a history of childhood ADHD in first-episode psychosis (2015) (14)
Source retrieval is not properly differentiated from object retrieval in early schizophrenia: An fMRI study using virtual reality (2014) (14)
Sensitivity of tests to assess improvement in ADHD symptomatology. (2004) (14)
Efficacy of Methylphenidate in ADHD Children across the Normal and the Gifted Intellectual Spectrum. (2012) (14)
The role of self-esteem for outcome in first-episode psychosis (2012) (14)
Predictors of ‘all-cause discontinuation’ of initial oral antipsychotic medication in first episode psychosis (2018) (14)
Epistatic interaction between 5HTTLPR and TPH2 polymorphisms predicts novelty seeking in women with bulimia nervosa spectrum disorders (2013) (14)
COVID-19 and the Future with Digital Mental Health: Need for Attention to Complexities (2020) (13)
Generalizing Duchenne to Sad Expressions With Binocular Rivalry and Perception Ratings (2019) (13)
Verbal but not performance IQ is highly correlated to externalizing behavior in boys with ADHD carrying both DRD4 and DAT1 risk genotypes (2009) (13)
CAA insertion polymorphism in the 3'UTR of Nogo gene on 2p14 is not associated with schizophrenia. (2005) (13)
Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer’s Disease (2017) (13)
Improving mental health services for homeless youth in downtown Montreal, Canada: Partnership between a local network and ACCESS Esprits ouverts (Open Minds), a National Services Transformation Research Initiative (2019) (12)
Molecular-genetic correlates of self-harming behaviors in eating-disordered women: Findings from a combined Canadian–German sample (2011) (12)
Transforming youth mental health services in a large urban centre: ACCESS Open Minds Edmonton (2019) (12)
Timing, Distribution, and Relationship Between Nonpsychotic and Subthreshold Psychotic Symptoms Prior to Emergence of a First Episode of Psychosis. (2021) (12)
Sensitivity of scales to evaluate change in symptomatology with psychostimulants in different ADHD subtypes. (2013) (12)
Improving youth mental wellness services in an Indigenous context in Ulukhaktok, Northwest Territories: ACCESS Open Minds Project (2019) (12)
Polymorphism of the 5-HT 2 A receptor gene : Association with stress-related indices in healthy middle-aged adults (2007) (12)
Placebo response and its determinants in children with ADHD across multiple observers and settings: A randomized clinical trial (2018) (12)
Impact of childhood trauma on positive and negative symptom remission in first episode psychosis (2021) (11)
Social Determinants of Health and Preclinical Glycemic Control in Newly Diagnosed First-Episode Psychosis Patients (2018) (11)
An algorithmic approach to the management of insomnia in patients with schizophrenia. (2017) (11)
Scrapbook interviewing and children with attention-deficit hyperactivity disorder (2012) (11)
Family-based association study of ADHD and genes increasing the risk for smoking behaviours (2012) (11)
Genetics of developmental psychiatric disorders: pathways to discovery. (2005) (11)
Chromosome 11‐q24 region in Tourette syndrome: Association and linkage disequilibrium study in the French Canadian population (2005) (11)
Caught in the "NEET Trap": The Intersection Between Vocational Inactivity and Disengagement From an Early Intervention Service for Psychosis. (2019) (11)
Clozapine for the management of persistent catatonia. (2016) (10)
Description, evaluation and scale‐up potential of a model for rapid access to early intervention for psychosis (2018) (10)
Outcome in patients converting to psychosis following a treated clinical high risk state (2018) (10)
Apgar Scores Are Associated with Attention-Deficit/Hyperactivity Disorder Symptom Severity (2016) (10)
Exome sequencing of sporadic childhood‐onset schizophrenia suggests the contribution of X‐linked genes in males (2018) (10)
Prepulse inhibition (PPI) of tactile startle response in recombinant congenic strains of mice: QTL mapping and comparison with acoustic PPI. (2008) (9)
On the simple and the complex in psychiatry, with reference to DSM 5 and research domain criteria. (2013) (9)
FC5C UNDERSTANDING THE COMPLEXITIES OF DELAY IN TREATMENT OF PSYCHOSIS AND RELEVANCE FOR EARLY DETECTION INTERVENTIONS (2006) (9)
Context and contact: a comparison of patient and family engagement with early intervention services for psychosis in India and Canada (2020) (9)
ACCESS Open Minds at the University of Alberta: Transforming student mental health services in a large Canadian post‐secondary educational institution (2019) (9)
Transforming youth mental health care in a semi‐urban and rural region of Canada: A service description of ACCESS Open Minds Chatham‐Kent (2019) (9)
Manualized Group Cognitive-Behavioral Therapy for Social Anxiety in At-Risk Mental State and First Episode Psychosis: A Pilot Study of Feasibility and Outcomes (2016) (9)
The 1000 Genomes Project: deep genomic sequencing waiting for deep psychiatric phenotyping. (2011) (9)
DRD4 exon 3 genotype and ADHD: Randomised pharmacodynamic investigation of treatment response to methylphenidate (2019) (9)
Catechol-O-Methyltransferase Gene and Executive Function in Children With ADHD (2014) (8)
A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis (2020) (8)
Editorial: How youth mental healthcare is being transformed in diverse settings across Canada: Reflections on the experience of the ACCESS Open Minds network (2019) (8)
Is olanzapine a brain-sparing medication? (2006) (8)
Anxiety symptoms severity and short‐term clinical outcome in first‐episode psychosis (2013) (8)
Treatment of ADHD in patients with bipolar disorder. (2017) (8)
Neurocognitive functions in persistent negative symptoms following a first episode of psychosis (2021) (7)
Dynamic endophenotypes and longitudinal trajectories: capturing changing aspects of development in early psychosis. (2016) (7)
Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophrenia (2006) (7)
Promoting measured genes and measured environments: on the importance of careful statistical analyses and biological relevance. (2007) (7)
Effects of Methylphenidate on Acute Math Performance in Children with Attention-Deficit Hyperactivity Disorder (2013) (7)
117 – Is any one method of measuring medication adherence in first-episode psychosis better than others? (2008) (7)
LRRTM1 protein is located in the endoplasmic reticulum (ER) in mammalian cells (2007) (7)
The Effects of Methylphenidate (Ritalin) on the Neurophysiology of the Monkey Caudal Prefrontal Cortex (2019) (7)
Identification of Informative Strains and Provisional QTL Mapping of Amphetamine (AMPH)-Induced Locomotion in Recombinant Congenic Strains (RCS) of Mice (2006) (6)
Decreased tooth size in schizophrenia (2009) (6)
A Model of Mental Health Care Involving Trained Lay Health Workers for Treatment of Major Mental Disorders Among Youth in a Conflict-Ridden, Low-Middle Income Environment: Part I Adaptation and Implementation (2019) (6)
Parent-of-origin effect and risk for attention-deficit/hyperactivity disorder: balancing the evidence against bias and chance findings. (2006) (6)
Early Medication Adherence and Insight Change in First-Episode Psychosis (2010) (6)
Altered hippocampal centrality and dynamic anatomical covariance of intracortical microstructure in first episode psychosis (2020) (6)
M114. DELUSIONAL CONTENT AT INITIAL PRESENTATION TO A CATCHMENT-BASED EARLY INTERVENTION SERVICE FOR PSYCHOSIS (2020) (6)
Obstetric complications in children with Attention Deficit/Hyperactivity Disorder and Learning Disability (2020) (6)
Cognitive capacity similarly predicts insight into symptoms in first- and multiple-episode psychosis (2019) (6)
Medication adherence in first episode psychosis: the role of pre‐onset subthreshold symptoms (2019) (6)
Bipolar disorder risk gene FOXO6 modulates negative symptoms in schizophrenia: a neuroimaging genetics study (2017) (6)
Economic Evaluation of Extended Early Intervention Service vs Regular Care Following 2 Years of Early Intervention: Secondary Analysis of a Randomized Controlled Trial. (2020) (6)
Do Unremitted Psychotic Symptoms Have an Effect on the Brain? A 2-Year Follow-up Imaging Study in First-Episode Psychosis (2020) (6)
Baby or bathwater? Referrals of “non-cases” in a targeted early identification intervention for psychosis (2018) (6)
Factor Structure of the Restricted Academic Situation Scale (2009) (6)
Perceived utility of biological testing for autism spectrum disorder is associated with child and family functioning. (2020) (6)
Deconstructing the mental health crisis in only 2 pieces. (2016) (6)
DRD3 Gene and ADHD: A Pharmaco-Behavioural Genetic Study (2018) (6)
The effect of intranasal oxytocin on perceiving and understanding emotion on the Mayer-Salovey-Caruso Emotional Intelligence Test (2012) (5)
The New Wave of Youth Mental Health Services: Time for Reflection and Caution (2020) (5)
Association between distress and knowledge among parents of autistic children (2019) (5)
[Sequence in prescribing neuroleptics: a therapeutic alternative in refractory schizophrenia?]. (1994) (5)
Effectiveness of Community Treatment Order in Patients with a First Episode of Psychosis: A Mirror-Image Study (2018) (5)
A RANDOMIZED CONTROLLED EVALUATION OF “EXTENDED SPECIALIZED EARLY INTERVENTION SERVICE” VS. “REGULAR CARE” FOR LONG-TERM MANAGEMENT OF EARLY PSYCHOSIS: A PILOT STUDY (2010) (5)
Adipose tissue dysregulation at the onset of psychosis: Adipokines and social determinants of health (2020) (5)
Neural function in DCC mutation carriers with and without mirror movements (2019) (5)
Whose responsibility? Part 1 of 2: A scale to assess how stakeholders apportion responsibilities for addressing the needs of persons with mental health problems (2022) (4)
Mode of entry to an early intervention service for psychotic disorders: determinants and impact on outcome. (2013) (4)
The effect of second-generation antipsychotics on basal ganglia and thalamus in first-episode psychosis patients (2019) (4)
Socioeconomic deprivation and blood lipids in first-episode psychosis patients with minimal antipsychotic exposure: Implications for cardiovascular risk (2019) (4)
Serotonin transporter, stressful life events, and depression severity. (2007) (4)
Dynamic Interplay Between Insight and Persistent Negative Symptoms in First Episode of Psychosis: A Longitudinal Study. (2021) (4)
Testing the Effectiveness of Implementing a Model of Mental Healthcare Involving Trained Lay Health Workers in Treating Major Mental Disorders Among Youth in a Conflict-Ridden, Low-Middle Income Environment: Part II Results (2019) (4)
Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis. (2019) (4)
Dissecting genetic cross-talk between ADHD and other neurodevelopmental disorders: Evidence from behavioural, pharmacological and brain imaging investigations (2018) (4)
Pre-onset sub-threshold psychotic symptoms and cortical organization in the first episode of psychosis (2020) (4)
Intersection of verbal memory and expressivity on cortical contrast and thickness in first episode psychosis (2019) (4)
Does an integrated outreach intervention targeting multiple stages of early psychosis improve the identification of individuals at clinical high risk? (2018) (3)
Adaptation and validation of the Genetic Counseling Outcome Scale for autism spectrum disorders and related conditions (2020) (3)
Increased exonic de novo mutation rate in individuals with SCZ (2011) (3)
Association between COMT methylation and response to treatment in children with ADHD. (2021) (3)
Unfinished business: Functional outcomes in a randomized controlled trial of a three‐year extension of early intervention versus regular care following two years of early intervention for psychosis (2021) (3)
Pharmacogenomics and animal models of schizophrenia (2003) (3)
Understanding sex differences in cognitive insight across first-and-multiple episode psychosis (2020) (3)
No Relation between Therapeutic Response to Methylphenidate and its Cardiovascular Side Effects in Children with Attention-Deficit/Hyperactivity Disorder (2008) (3)
EVIDENCE FOR WIDESPREAD THINNING OF THE CEREBRAL CORTEX IN PATIENTS WITH FIRST-EPISODE PSYCHOSIS WITH POOR INSIGHT (2010) (3)
Serotonin syndrome: SSRIs are not the only culprit (2021) (3)
Can electroencephalography (EEG) identify ADHD subtypes? A systematic review (2022) (3)
Supplementary Table 3 (2011) (3)
How Environmental Factors Can Get Under the Skin: Epigenetics in Attention-Deficit/Hyperactivity Disorder. (2017) (3)
0374 ENVIRONMENTAL RISK FACTORS FOR SCHIZOPHRENIA AND PSYCHOSIS PRONENESS IN A COMMUNITY SAMPLE: MAIN EFFECTS AND INTERACTIONS WITH GENOTYPE (2006) (3)
Recollection rejection of new items in individuals with first-episode psychosis. (2016) (3)
Sex-dependent complex association of TPH2 with multiple dimensions of ADHD (2021) (3)
COMT by DRD3 Epistatic Interaction in Modulating Behaviors in Children with ADHD: A Pharmaco-Dynamic Behavioral Approach (2020) (3)
Randomness and nondeterminism: from genes to free will with implications for psychiatry (2021) (3)
Dr. Turecki and Colleagues Reply (2000) (3)
Facing the Methodological Challenge in Dissecting the Genetics of ADHD: A Case for Deep Phenotyping and Heterogeneity Reduction. (2020) (3)
Emotion Perception is Valence-Dependent during Binocular Rivalry. (2015) (2)
Patient Stratification Using Metabolomics to Address the Heterogeneity of Psychosis (2020) (2)
Polymorphism in the cell division cycle 45 like gene and schizophrenia. (2001) (2)
Motion perception in schizophrenic patients (1998) (2)
A Digital Health Innovation to Prevent Relapse and Support Recovery in Youth Receiving Specialized Services for First-Episode Psychosis: Protocol for a Pilot Pre-Post, Mixed Methods Study of Horyzons-Canada (Phase 2) (2021) (2)
Whose responsibility? Part 2 of 2: views of patients, families, and clinicians about responsibilities for addressing the needs of persons with mental health problems in Chennai, India and Montreal, Canada (2022) (2)
Investigating subjective cognitive complaints in psychosis: Introducing the brief scale to Investigate cognition in schizophrenia (SSTICS-Brief) (2020) (2)
Community Assessment of Psychic Experiences--English Version (2012) (2)
Suicidality Over the First 5 Years of Psychosis: Does Extending Early Intervention Have Benefits? (2020) (2)
Next-generation gene panel testing in adolescents and adults in a medical neuropsychiatric genetics clinic (2021) (2)
T87. TOWARD DEVELOPING CLINICAL CUTOFF VALUES FOR THE BECK COGNITIVE INSIGHT SCALE (2018) (2)
Progress of negative symptoms over the initial 5 years of a first episode of psychosis – CORRIGENDUM (2018) (2)
S231. Intracortical and Superficial White Matter Microstructural Changes After a First Episode of Psychosis (2018) (2)
Meeting the challenges of the new frontier of youth mental health care (2022) (2)
DNA methylation in people with anorexia nervosa: Epigenome-wide patterns in actively ill, long-term remitted, and healthy-eater women (2022) (2)
Who should be "controls" in studies on the neurobiology of psychiatric disorders? (2018) (2)
Therapeutic Response to Methylphenidate in ADHD: Role of Child and Observer Gender. (2020) (2)
Acute blood pressure change with methylphenidate is associated with improvement in attention performance in children with ADHD (2020) (2)
[Electroconvulsive therapy and schizophrenia. Update from the data of the literature]. (1991) (2)
Estimating and Correcting Optimism Bias in Multivariate PLS Regression: Application to the Study of the Association Between Single Nucleotide Polymorphisms and Multivariate Traits in Attention Deficit Hyperactivity Disorder (2014) (2)
From the neo-Kraepelinian framework to the new mechanical philosophy of psychiatry: regaining common sense (2019) (2)
Pragmatic implementation of the Clinical Global Impression Scale of Severity as a tool for measurement-based care in a first-episode psychosis program (2022) (2)
Polyglutamine tracts in schizophrenia: gaining new insights (2000) (1)
An observational study of antipsychotic medication discontinuation in first-episode psychosis: clinical and functional outcomes (2022) (1)
0415 LIFETIME TRAUMA, DISSOCIATION AND POSITIVE SYMPTOMS IN PSYCHOSIS (2006) (1)
Adapting, updating and translating the Social Functioning Scale to assess social, recreational and independent functioning among youth with psychosis in diverse sociocultural contexts (2021) (1)
M3 GENE-GENE INTERACTION BETWEEN COMT AND NET IN MODULATING ADHD BEHAVIORS (2019) (1)
497 Brain dopa-decarboxylase (DDC) activity in unmedicated schizophrenic patients (1997) (1)
Investigation of rare variants in LRP1, KPNA1, ALS2CL and ZNF480 genes in schizophrenia patients reflects genetic heterogeneity of the disease (2013) (1)
P.3.e.020 Early medication adherence and insight change in first episode psychosis (2009) (1)
Measurement Based Care in a first episode psychosis program: Development of an algorithm of care based on the Clinical Global Impressions Scale. (2022) (1)
Fit for purpose: Conception and psychometric evaluation of developmentally appropriate measures to assess functional recovery in first-episode psychosis across geo-cultural contexts. (2021) (1)
Ruminative response style moderates the effect of oxytocin on autobiographical memory recall (2015) (1)
Predictors of empowerment in parents of children with autism and related neurodevelopmental disorders who are undergoing genetic testing (2021) (1)
Implications of early signs and symptoms for diagnostic trajectories in first-episode psychosis (2008) (1)
SU6 SYNERGISTIC EFFECT OF COMT AND KIAA0319 GENES IN MODULATING ADHD BEHAVIORS (2019) (1)
The orphan receptor GPR88 controls impulsivity and is a risk factor for Attention-Deficit/Hyperactivity Disorder (2022) (1)
Altered emotional modulation of associative memory in first episode schizophrenia: An fMRI study (2015) (1)
Patient satisfaction with random assignment to extended early intervention for psychosis vs regular care: Relationship with service engagement (2020) (1)
T178. PRIOR SUB-THRESHOLD PSYCHOTIC SYMPTOMS ASSOCIATED WITH THICKER RIGHT INFERIOR FRONTAL GYRUS AMONG PATIENTS IN A FIRST EPISODE OF PSYCHOSIS (2018) (1)
Reducing the dimensions of psychotic illness (2022) (1)
Synaptic Abnormalities and Candidate Genes in Autism (2006) (1)
Utilizing pharmacogenetics when treating first episode psychosis (2023) (1)
Cumulative exposure to ADHD medication is inversely related to hippocampus subregional volume in children (2021) (1)
The value of a skeptical approach to neurosciences in psychiatric training and practice. (2017) (1)
Are mental disorders orphan diseases? (2020) (1)
O7.2. ALTERED HIPPOCAMPAL CENTRALITY IN RELATION TO COORDINATED CHANGES OF INTRACORTICAL MICROSTRUCTURE IN FIRST EPISODE PSYCHOSIS (2019) (1)
Sitting on the edge: when to treat symptoms of inattention without the full DSM-IV criteria of ADHD. (2007) (1)
Sex-specific associations in verbal memory brain circuitry in early psychosis. (2022) (1)
The effects of childhood adversity on treatment delays and its components in first-episode psychosis (2021) (1)
Medial temporal lobe and basal ganglia volume trajectories in persistent negative symptoms following a first episode of psychosis (2022) (1)
34.1 DO ALL INDIVIDUALS WITH A FEP PASS THROUGH AN EARLIER CHR-P STATE? IMPLICATIONS FOR CLINICAL STAGING, EARLY DETECTION AND PHASE-SPECIFIC INTERVENTIONS (2018) (1)
Sex differences in anxiety and depression in children with attention deficit hyperactivity disorder: Investigating genetic liability and comorbidity (2021) (1)
Dynamic association of the first identifiable symptom with rapidity of progression to first-episode psychosis (2021) (1)
“The more things change…”? Stability of delusional themes across 12 years of presentations to an early intervention service for psychosis (2022) (1)
Therapeutic response in children with ADHD: role of observers and settings (2020) (1)
Treating anxious syndromes with pregabalin in patients with psychosis. (2020) (1)
The impact of caregiver familiarity with mental disorders on timing of intervention in first‐episode psychosis (2015) (1)
39-50 CAG repeat containing genes and schizophrenia: An association study (1997) (0)
M47 Whole Exome Sequencing of Affected Individuals From Large Consanguineous Pedigrees With Psychotic/Affective Disorders From Pakistan (2017) (0)
254. Neural substrates of eye tracking deficits in relatives of schizophrenics (1996) (0)
Digital health innovation to prevent relapse and support recovery in young people with first-episode psychosis: A pilot study of Horyzons-Canada (2023) (0)
Look Before You Leap: Representativeness of Those Completing Self-Reports in Early Psychosis Research (2020) (0)
T41. SEX DIFFERENCES IN VERBAL MEMORY IN FIRST-EPISODE PSYCHOSIS AND HEALTHY CONTROLS (2019) (0)
The Canadian Coalition for Seniors’ Mental Health (CCSMH) and Canadian Academy of Geriatric Psychiatry (CAGP) Joint Scientific Meeting (2014) (0)
Comparing the influences of emotion versus identity on face perception during binocular rivalry in human observers (2014) (0)
Examining the psychobiological response to acute social stress across clinical stages and symptom trajectories in the early psychosis continuum. (2023) (0)
Poster #S133 ASSOCIATION OF A RISK ALLELE OF ANK3 WITH COGNITIVE PERFORMANCE AND CORTICAL THICKNESS IN PATIENTS WITH FIRST-EPISODE PSYCHOSIS (2014) (0)
83-3 Developmental stability and minor physical anomalies in schizophrenic patients (1997) (0)
Reply to Bellivier et al. (1998) (0)
Poster #96 COMPARING THE CLINICAL PRESENTATION OF FIRST EPISODE PSYCHOSIS ACROSS DIFFERENT MIGRANT AND ETHNIC MINORITY GROUPS IN MONTREAL, CANADA (2012) (0)
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency (2019) (0)
The differential impact of severe childhood trauma on emotion recognition in males and females with first-episode psychosis (2021) (0)
Context and Expectations Matter: Social, Recreational, and Independent Functioning among Youth with Psychosis in Chennai, India and Montreal, Canada. (2023) (0)
DRD3 Gene and ADHD: A Pharmaco-Behavioural Genetic Study (2018) (0)
Psychiatry is the flagship of personalized and precision medicine: proposing an epistemic horizon to biological psychiatry (2022) (0)
SA3 REDUCED CORTICAL THICKNESS IN CHILDREN WITH ADHD: ROLE OF NET16 AND MATERNAL SMOKING DURING PREGNANCY (2019) (0)
Subtyping negative symptoms in first-episode psychosis: Contrasting persistent negative symptoms with a data-driven approach (2022) (0)
M112. Clozapine Use in Early-Intervention Programs Across Canada (2017) (0)
Exit exceptionalism: mental disease is like any other medical disease - Author response. (2015) (0)
The BDNF val66met polymorphism is associated with decreased use of landmarks and decreased fMRI activity in the hippocampus during virtual navigation (2021) (0)
375 – Neurocognitive correlates of cognitive insight in first episode psychosis (2008) (0)
A Roof for Recovery: Combining the Principles of Housing First and Early Intervention in Services for People with Psychosis (2019) (0)
Understanding the Pharmacogenetics of ADHD (2007) (0)
PMH26 Direct Cost of Schizophrenia in Quebec, Canada: An Incidence-Based Microsimulation Monte-Carlo Markov Model (2011) (0)
0464 REDUCING DELAY IN TREATMENT OF PSYCHOSIS: A SERVICE MODEL FACILITATING EARLY CASE IDENTIFICATION, ENGAGEMENT AND ASSESSMENT (2006) (0)
SMOKING STATUS AND ITS RELATIONSHIP TO CLINICAL AND DEMOGRAPHIC CHARACTERISTICS IN FIRST EPISODE PSYCHOSIS (2015) (0)
Transsyndromic trajectories from pre-onset self-harm and subthreshold psychosis to the first episode of psychosis: A longitudinal study. (2023) (0)
Steroid receptors/co-receptors and schizophrenia: An association study (1998) (0)
STRUCTURAL NEURAL CORRELATES OF VERBAL MEMORY IN FIRST EPISODE SCHIZOPHRENIA (2010) (0)
Stress-induced Dopamine Release in Relatives of Schizophrenic Patients (2009) (0)
S96. EXAMINING DIFFERENCES BETWEEN CURRENT CANNABIS CONSUMPTION AND COGNITIVE FUNCTIONING OF FIRST-EPISODE PSYCHOSIS PATIENTS: A RETROSPECTIVE STUDY (2020) (0)
SA53. Is It Useful to Force First-Episode Psychosis Patients to Comply With Medications? Another Look at Community Treatment Orders (2017) (0)
Family history and APOE4 risk for Alzheimer’s Disease impact the neural correlates of episodic memory by early midlife (2017) (0)
FOXO6 gene confers protection against negative symptoms in schizoprenia (2015) (0)
S51. SEX DIFFERENCES IN COGNITIVE INSIGHT AMONG INDIVIDUALS WITH FIRST-AND-MULTIPLE EPISODE PSYCHOSIS (2019) (0)
Original Article A 12-month outcome study of insight and symptom change in first-episode psychosis (2010) (0)
3.5 Math Difficulties and ADHD: Understanding the Executive Function and Clinical Profiles (2022) (0)
Cortical thinning and structural covariance in a subset of first episode psychosis patients exhibiting persistent negative symptoms (2015) (0)
Response to the letter “Actigraphic evaluation for patients with attention deficit/hyperactivity disorder” (2013) (0)
Genetic Evidence for the Association of the Hypothalamic–Pituitary–Adrenal (HPA) Axis with ADHD and Methylphenidate Treatment Response (2012) (0)
Normal-range verbal memory in the first-episode of psychosis: Clinical and functional outcomes across 24 months and impact of estimated verbal memory decrement (2022) (0)
DISRUPTED WHITE MATTER INTEGRITY OF THE SUPERIOR CEREBELLAR PEDUNCLE IS ASSOCIATED WITH NEUROCOGNITIVE IMPAIRMENTS IN PATIENTS WITH RECENT-ONSET SCHIZOPHRENIA (2019) (0)
Severe childhood trauma and emotion recognition in males and females with first‐episode psychosis (2022) (0)
The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder (2021) (0)
Author Correction: Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder (2021) (0)
Poster #14 HOW DOES MATERNAL INFLAMMATION IN THE MOUSE RESULTIN ALTERATIONS IN GAD67 AND REELIN EXPRESSION IN THE HIPPOCAMPUS? (2012) (0)
Poster #S63 REDUCED HIPPOCAMPAL VOLUME IN MALE BUT NOT FEMALE PATIENTS WITH FIRST EPISODE PSYCHOSIS: RELATIONSHIP TO CORTISOL LEVELS AND SYMPTOMS (2014) (0)
Symposium (1987) (0)
Author Correction: Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains (2023) (0)
Genetic, environmental and other design issues relevant for pharmacogenetics studies (2007) (0)
O3.5. EARLY TRAJECTORIES OF POSITIVE SYMPTOMS REMISSION IN FIRST EPISODE-PSYCHOSIS: A 2-YEAR FOLLOW-UP STUDY (2020) (0)
O6.8. THE EXTERNAL VALIDITY OF EARLY PSYCHOSIS RESEARCH: IMPLICATIONS FOR UNDERSTANDING CLINICAL POPULATIONS AND MEASUREMENT-BASED CARE (2019) (0)
Comparing treatment delays and pathways to early intervention services for psychosis in urban settings in India and Canada (2022) (0)
Genesis, modelling and methodological remedies to autism heterogeneity (2023) (0)
Corrigendum to “Therapeutic Effectiveness and Tolerability of Aripiprazole as Initial Choice of Treatment in First Episode Psychosis in an Early Intervention Service: A One-Year Outcome Study” [Schizophr. Res. 147, 120-125] (2018) (0)
MC6 SCHIZOPHRENIA MODELING: MARKOV MODEL WITH MONTE-CARLO MICROSIMULATION (2009) (0)
Case-manager and patient-rated alliance as a predictor of medication adherence in first-episode psychosis (2011) (0)
Whose responsibility is it to address the needs of persons with mental health problems? Development of a scale to assess how stakeholders distribute responsibilities across geo-cultural contexts (2021) (0)
Severe Childhood Trauma Differentially Impacts Emotion Recognition in Males and Females with First-Episode Psychosis (2020) (0)
Update on the review process and publishing at the Journal of Psychiatry & Neuroscience. (2014) (0)
A Digital Health Innovation to Prevent Relapse and Support Recovery in Youth Receiving Specialized Services for First-Episode Psychosis: Protocol for a Pilot Pre-Post, Mixed Methods Study of Horyzons-Canada (Phase 2) (Preprint) (2021) (0)
SU91. Evaluating Accuracy of Basal Ganglia Segmentation Methods: Comparing Automated Approaches to Manual Delineation (2017) (0)
0431 SIMILAR BRAIN PROCESSES MAKE MEMORY DURABLE IN PEOPLE WITH FIRST EPISODE OF PSYCHOSIS AND IN HEALTHY INDIVIDUALS (2006) (0)
WC10D INTERACTIONS BETWEEN GENES AND CHILDHOOD TRAUMA IN EXPLAINING SYMPTOM SEVERITY IN SCHIZOPHRENIA (2006) (0)
Altered affective, executive and sensorimotor resting state networks inpatients with pediatric mania (2015) (0)
39-49 Polyglutamin containing proteins in schizophrenia (1997) (0)
Manualized group cognitive behavioral therapy for social anxiety in first-episode psychosis: a randomized controlled trial. (2022) (0)
Adaptation of a Digital Health Innovation to Prevent Relapse and Support Recovery in Youth Receiving Services for First-Episode Psychosis: Results From the Horyzons-Canada Phase 1 Study (Preprint) (2020) (0)
Conditional associations between childhood cat ownership and psychotic experiences in adulthood: A retrospective study. (2022) (0)
Young Adults' Perspectives on Factors Related to Relapse After First-Episode Psychosis: Qualitative Focus Group Study. (2022) (0)
Author's response (2022) (0)
Psychosis: Clinical evaluation for inborn errors of metabolism (2014) (0)
Medium range cognitive impairment (MeRCI) hypothesis for psychosis formation: evidence from epidemiological studies and recent molecular genetic developments. (2014) (0)
M2 ANALYZING THE ROLE OF COMMON EXOMIC VARIANTS ON MODULATING ADHD BEHAVIORS USING A BEHAVIORAL DYNAMIC APPROACH (2019) (0)
Face Inversion Disrupts Holistic Processing of Duchenne Emotions during Binocular Rivalry (2016) (0)
S003329171800048Xjra 66..74 (2018) (0)
Comorbid anxiety and short-term clinical outcome in first episode psychosis (2011) (0)
Global and regional cortical thickness associations with general and domain-specific cognition in first-episode psychosis (2021) (0)
Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophrenia (2022) (0)
Using dimensionality-reduction techniques to understand the organization of psychotic symptoms in persistent psychotic illness and first episode psychosis (2023) (0)
T172. MULTIMODAL QUANTIFICATION OF MEMORY CIRCUIT MICROSTRUCTURE IN FIRST EPISODE PSYCHOSIS (2018) (0)
Community Assessment of Psychic Experiences--French Version (2012) (0)
170. Increased genetic liability to schizophrenia-spectrum disorders in first degree relatives of neuroleptic-resistant schizophrenic patients (1996) (0)
Relation between child abuse and/or neglect and hippocampal volumes, and cortical thickness, in first episode psychosis patients (2010) (0)
DRD 4 Exon 3 Genotype and ADHD : Randomized Pharmacodynamic Investigation of Treatment Response to Methylphenidate Running title : Dopamine receptor 4 Genotype in Childhood ADHD (2017) (0)
Probing Myelin in First Episode of Psychosis With MRI: A Framework to Understand Negative Symptoms and Verbal Memory (2020) (0)
The 26th Annual Meeting of the Canadian College of Neuropsychopharmacology: Montréal, Quebec, Canada, June 1–4, 2003 (2003) (0)
Gene and Executive Function in Children With ADHD Catechol-O-Methyltransferase (2012) (0)
Clozapine-Induced Agranulocytosis Revealing a Hemophagocytic Lymphohistiocytosis: A Case Report (2018) (0)
P.3.e.009 The role of social support and therapeutic alliance in promoting adherence to medication in first episode psychosis (2009) (0)
M90. Associations of Cortical Thickness With Awareness of Illness in Enduring Schizophrenia (2017) (0)
S59. LINKING VERBAL MEMORY DEFICITS, HIPPOCAMPAL VOLUME, AND FUNCTIONING: SEX DIFFERENCES ARE CRUCIAL (2020) (0)
Predictors of treatment attrition of cognitive health interventions in first episode psychosis. (2023) (0)
Source retrieval is not properly differentiated from object retrieval in early schizophrenia: a functional magnetic resonance imaging (fMRI) study using virtual reality (2014) (0)
Symptoms of childhood disorders are common and predict future cannabis use in individuals with first episode psychosis (2011) (0)
Differential Trajectories of Delusional Content and Severity Over 2 Years of Early Intervention for Psychosis: Comparison Between Chennai, India, and Montréal, Canada. (2023) (0)
TH64. NEXT GENERATION GENE PANEL SEQUENCING: LESSONS FROM OUR MEDICAL NEUROPSYCHIATRIC GENETICS CLINIC EXPERIENCE (2021) (0)
Trust of patients and families in mental healthcare providers and institutions: A cross-cultural study in Chennai, India and Montreal, Canada (2023) (0)
144 – Blunted cortisol response to awakening in men with first episode psychosis (2008) (0)
T94. CORTICAL THICKNESS TRAJECTORIES IN RELATION TO CHANGES IN EXECUTIVE FUNCTION AMONG FIRST EPISODE PSYCHOSIS PATIENTS (2019) (0)
ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), ONE OF THE MOST PREVALENT CONDITIONS IN CHILD PSYCHIATRY, MANIFESTS AS AN UNUSUALLY (2007) (0)
Cover Image, Volume 30, Issue 10 (2020) (0)
The 43rd Annual Meeting of the Canadian College of Neuropsychopharmacology, November 4, 2021 (2022) (0)
Probing Myelin in First Episode of Psychosis With MRI: A Framework to Understand Negative Symptoms and Verbal Memory (2021) (0)
[The genetics of schizophrenia: back to the clinic?]. (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ridha Joober?

Ridha Joober is affiliated with the following schools:

McGill University

Ridha Joober's Academic­Influence.com Rankings

Ridha Joober's Degrees

Why Is Ridha Joober Influential?

Ridha Joober's Published Works

Published Works

What Schools Are Affiliated With Ridha Joober?

Ridha Joober's AcademicInfluence.com Rankings